Investor's Business Daily on MSN5d
Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit WinAnd Catalyst Pharmaceuticals stock is one of those that seems to be thriving. Catalyst is Thursday's selection for IBD 50 ...
TipRanks on MSN7d
Merck (NYSE:MRK) Becomes Latest Big Pharma Stock to Tap China with $2B Heart Disease Drug Rights DealMerck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 ...
With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...
Cambridge: Harbour BioMed, a global biopharmaceutical company has announced a global strategic collaboration with AstraZeneca ...
Shares of Harbour BioMed soared after the Chinese biopharmaceutical firm announced a collaboration with U.K. pharma giant AstraZeneca, which plans to invest $2.5 billion in China. The stock rose as ...
Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback